4.1 Review

Recent Formulation Advances of Mangiferin

Publisher

SPRINGERNATURE
DOI: 10.1007/s43450-022-00297-z

Keywords

Nanocarrier; Nanotechnology; Xanthone; Natural compounds; Pharmacokinetics; Bioavailability

Funding

  1. Science, Technology & Innovation Funding Authority (STDF)
  2. The Egyptian Knowledge Bank (EKB)

Ask authors/readers for more resources

Nutraceuticals have shown valuable contributions in disease treatment, but their efficacy is limited by poor solubility. Delivery carriers can overcome these limitations and improve their pharmacological effects.
Nutraceuticals have recently gained interest owing to their valuable contribution in the treatment of several diseases, with high safety margin and low incidence of side effects. However, their efficacy is limited by some challenges, namely poor solubility, low permeability, and, consequently, low bioavailability. Delivery carriers have proven that they can overcome almost all the aforementioned limitations, leading to improvement in the pharmacological efficacy of nutraceuticals. Among the promising nutraceuticals that have currently evoked considerable interest is mangiferin from mango tree, which is a polyphenol exhibiting many favorable pharmacological actions, but unfortunately suffers from poor aqueous solubility and other limitations that lower its bioavailability and halter its efficacy. This review summarizes the pharmacological actions of mangiferin and provides an insight on how delivery carriers for mangiferin (lipidic, vesicular, polymeric, inorganic, and protein nanoparticles, as well as complexes) can overcome its pharmaceutical challenges, hence reflecting on its improved therapeutic effects in treatment of different diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available